Primary hyperparathyroidism can generate recurrent pancreatitis and secondary diabetes mellitus – A case report
Journal of Mind and Medical Sciences
Volume 6 | Issue 2
Article 26
2019
Primary hyperparathyroidism can generate
recurrent pancreatitis and secondary diabetes
mellitus – A case report
Nicoleta Mîndrescu
Georgeta Văcaru
Emil Ștefănescu
Loreta Guja
Rucsandra Elena Dănciulescu Miulescu
Follow this and additional works at: https://scholar.valpo.edu/jmms
Part of the Endocrinology, Diabetes, and Metabolism Commons, Gastroenterology Commons,
and the Internal Medicine Commons
Recommended Citation
Mîndrescu, Nicoleta; Văcaru, Georgeta; Ștefănescu, Emil; Guja, Loreta; and Dănciulescu Miulescu, Rucsandra Elena (2019) "Primary
hyperparathyroidism can generate recurrent pancreatitis and secondary diabetes mellitus – A case report," Journal of Mind and Medical
Sciences: Vol. 6 : Iss. 2 , Article 26.
DOI: 10.22543/7674.62.P361366
Available at: https://scholar.valpo.edu/jmms/vol6/iss2/26
This Case Presentation is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion in Journal of Mind and Medical
Sciences by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at .
https://scholar.valpo.edu/jmms/
https://proscholar.org/jmms/
ISSN: 2392-7674
J Mind Med Sci. 2019; 6(2): 361-366
doi: 10.22543/7674.62.P361366
Received for publication: July 06, 2019
Accepted: September 02, 2019
Case report
Primary hyperparathyroidism can generate
recurrent pancreatitis and secondary
diabetes mellitus – A case report
Nicoleta Mîndrescu1, Georgeta Văcaru2, Emil Ștefănescu3, Loreta Guja3, Rucsandra
Elena Dănciulescu Miulescu3,4
1
Nicodiab Private Practice, Bucharest, Romania
EasyDiet Private Practice, Bucharest, Romania
3
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
4
N.C. Paulescu National Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania
2
Abstract
Introduction. Acute or recurrent pancreatitis may be a complication of primary
hyperparathyroidism and patients with previous episodes of pancreatitis may develop secondary
diabetes mellitus. Case report. We describe the clinical case of a 52-year old Caucasian man
diagnosed with chronic recurrent pancreatitis in 2007. The first episode of acute pancreatitis
occurred in 2002, followed by another 4 episodes in 2004 and 2007. In 2004, papilosfincterectomy
was implemented with a stent mount that was removed one month later. In 2005, the patient
underwent a surgical intervention for the diagnosis of chronic lithiasis, and cholecystectomy was
performed. Additional investigations on the etiology of recurrent chronic pancreatitis, initially
diagnosed as idiopathic, revealed elevated values of total serum calcium, serum parathormone, and
the presence of a parathyroid adenoma in the right lower pole of the thyroid. In September 2007,
parathyroidectomy was performed with a favorable evolution and the remission of the acute
pancreatitis episodes. The patient had not had any family history of diabetes; in 2017 he was
diagnosed with diabetes. Conclusion. In cases of recurrent pancreatitis, screening for
hyperparathyroidism is recommended. Metabolic evaluation is required, because the risk of
developing diabetes in patients with recurrent pancreatitis is high.
Keywords
Highlights
✓ In cases of recurrent renal lithiasis or pancreatitis, screening for hyperparathyroidism is
recommended.
primary hyperparathyroidism, recurrent pancreatitis, secondary diabetes mellitus
✓ Metabolic evaluation is required in patients with recurrent pancreatitis because of their
high risk of developing diabetes.
To cite this article: Nicoleta Mîndrescu, Georgeta Văcaru, Emil Ștefănescu, Loreta Guja,
Rucsandra Elena Dănciulescu Miulescu. Primary hyperparathyroidism can generate recurrent
pancreatitis and secondary diabetes mellitus – A case report. J Mind Med Sci. 2019; 6(2): 361-366.
DOI: 10.22543/7674.62.P361366
*Corresponding author: Rucsandra Elena Dănciulescu Miulescu, Carol Davila University of Medicine and
Pharmacy, Bucharest, Romania
E-mail:
Nicoleta Mîndrescu et al.
Introduction
Primary hyperparathyroidism is an endocrine disorder
generated by the autonomous production of parathyroid
hormone (PTH). The prevalence of the disease varies
between 0.1% and 1.0 %, being the third endocrine disease
after diabetes and thyroid disorder. The affliction is
generated in most situations by a solitary parathyroid
adenoma. Other causes of primary hyperparathyroidism
include: multiple adenoma, hyperplasia of the four glands,
and parathyroid carcinoma (1). PTH acts on the bones,
kidneys, and small intestine. In the bones, PTH stimulates
osteoblasts directly and osteoclasts indirectly, which leads
to the release of calcium secondary to the resorption of the
bones. The effects of PTH on the kidneys include:
increased calcium reabsorption and decreased phosphate
reabsorption; and activation of the 1 α hydroxylase, an
enzyme that catalyzes the transformation of 25hydroxycholecalciferol (the inactive form of vitamin D) to
1,25-dihydroxycholecalciferol (the active form of vitamin
D). In the small intestine, the active form of vitamin D
ensures the absorption of calcium through two pathways:
active transcellular and passive paracellular pathway (2, 3).
The consequences of primary hyperparathyroidism are
hypercalcemia (but the normocalcemic variant is now
recognized), hypercalciuria, hypophosphatemia, damage
of the cortical and trabecular bones, renal, gastrointestinal,
cardiovascular, neuromuscular, and psychiatric symptoms.
The clinical form includes symptomatic or asymptomatic
diseases. Symptomatic primary hyperparathyroidism
occurs in countries where biochemical screenings are not
routinely used (4). The introduction of the serum
AutoAnalyzer in 1970 allowed the identification of
patients with asymptomatic hypercalcemia, and advances
in techniques to determine PTH have facilitated the
diagnosis of primary hyperparathyroidism (5).
Acute or recurrent pancreatitis may be a complication
of primary hyperparathyroidism (6, 7). The prevalence of
acute or recurrent pancreatitis in patients with primary
hyperparathyroidism has been estimated, according to
some studies, between 1.5% and 13% (5). A study
published in 2009 by Khoo and collaborators contradicts
previous reports. Their study included 684 patients with
primary hyperparathyroidism. 10 patients (1.5%)
developed acute pancreatitis compared to 32 out of the
1,368 (2.3%) from the control group. The authors
concluded that there is no causal relationship between
primary hyperparathyroidism and acute pancreatitis (8).
Subjects with previous episodes of pancreatitis may
develop diabetes mellitus. The prevalence of diabetes
secondary to pancreatitis is estimated between 5% and 10%
362
in the Western population (9, 10). In 2013, Ewald and
Bretzel suggested several diagnostic criteria for diabetes
mellitus secondary to pancreatic diseases, as follows:
“ 1) the presence of pancreatic exocrine insuffici (...truncated)